Skip to main content
logo
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.810
+0.220 (6.13%)
At close: Aug 24, 2026, 4:00 PM EDT
3.750
-0.060 (-1.57%)
After-hours: Aug 24, 2026, 6:56 PM EDT

Xenetic Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.262.982.52.541.711.16
Revenue Growth
33.30%19.04%-1.56%48.80%47.06%165.64%
Gross Profit
3.262.982.52.541.711.16
Operating Income
-2.64-2.83-4.2-4.52-6.72-5.75
Net Income
-2.48-2.68-3.96-4.13-6.55-5.65
Earnings Per Share
-1.19-1.58-2.57-2.71-4.61-5.49
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.477.886.178.9813.118.24
Total Debt
-0.01---0.03
Net Cash (Debt)
6.477.886.178.9813.118.22
Net Cash Growth
35.40%27.76%-31.36%-31.41%-28.10%58.89%
Net Cash Per Share
3.124.634.005.889.2117.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.31-2.29-2.82-4.11-4.65-4.74
Capital Expenditures
------
Free Cash Flow
-2.31-2.29-2.82-4.11-4.65-4.74
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-81.01%-95.23%-168.16%-177.78%-393.57%-495.12%
Pretax Margin
-75.91%-90.07%-158.39%-162.78%-383.87%-486.36%
Profit Margin
-75.91%-90.07%-158.39%-162.78%-383.87%-486.36%
FCF Margin
-70.93%-76.83%-112.69%-161.98%-272.23%-408.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.581.672.462.092.5314.88